Stay updated on Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, signaling a small maintenance update to the page. It does not indicate changes to the study results or core information.
    Difference
    0.1%
    Check dated 2026-08-08T19:16:23.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page's revision tag updates from v3.6.3 to v3.6.4, reflecting a newer internal version in the footer.
    Difference
    0.1%
    Check dated 2026-07-25T12:55:29.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page shows a revision tag updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a platform update. This change does not modify the study details, eligibility criteria, outcomes, or other content presented on the page.
    Difference
    0.1%
    Check dated 2026-07-04T04:11:10.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Footer revision updated from v3.6.0 to v3.6.2, signaling a minor platform update to the Study page. This change does not modify study content or visible functionality.
    Difference
    0.1%
    Check dated 2026-06-27T02:03:40.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added recruitment status text No longer looking for participants and new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) with a formatting update to the Intervention/Treatment label. Removed the old Intervention / Treatment heading and updated the revision to Revision: v3.6.0 replacing v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-12T16:07:17.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.5.5, replacing the previous v3.5.4. This reflects a minor maintenance update rather than a content change.
    Difference
    0.1%
    Check dated 2026-06-05T11:31:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page.